Product Information
DORZOLAMIDE-TIMOLOL 2-0.5%(PF) is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.1012 per EA under NDC 50742032360. Its NADAC has been published 151 times since Aug 9, 2023.
Strength
20; 5 mg/mL; mg/mL
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742032360
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA217260On Market Since
5/2/2023
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has been published 151 times since Aug 9, 2023, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1012 per EA |
|---|---|
| All-time high | $1.7918 (Dec 13, 2023) |
| All-time low | $0.9746 (Nov 20, 2024) |
| 52-week high | $1.2479 |
| 52-week low | $1.0471 |
| Median price | $1.2367 |
| Average price | $1.2985 |
| Largest weekly change | +40.7% (Jun 19, 2024) |
| Weeks tracked | 151 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dorzolamide hydrochloride and timolol maleate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL 2-0.5%(PF), manufactured by Ingenus Pharmaceuticals LLC, is $1.1012 per EA (NDC 50742032360), effective Jun 24, 2026.
How has the price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has declined 24.2%. It has been tracked across 151 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
Since Aug 9, 2023, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has ranged from a low of $0.9746 (Nov 20, 2024) to a high of $1.7918 (Dec 13, 2023), with a median of $1.2367 per EA.
Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DORZOLAMIDE-TIMOLOL 2-0.5%(PF), so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
DORZOLAMIDE-TIMOLOL 2-0.5%(PF) (NDC 50742032360) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification